How well do you understand skin cancer risks? Test yourself with our latest quiz, and learn about USPSF recommendations for skin cancer prevention.
Advertisement
Question 1
Answer
C.80%
According to the USPSTF 2018 updated recommendations for preventing skin cancer, invasive nonbasal and nonsquamous cell carcinoma skin cancers represent 2% of diagnosed skin cancers and 80% of skin cancer deaths in the United States.
Question 2
Answer
D.All of the above
According to the USPSTF's 2018 updated recommendations for preventing skin cancer, people defined as having fair skin types include those with ivory or pale skin, easily sunburned skin, light eye color, freckles, and/or red or blond hair. These individuals are at increased risk of skin cancer. Skin cancer risk is also affected by sunburn history and a family history of skin cancer.
Question 3
Answer
B.24 years
The USPSTF recommends that clinicians counsel patients and parents about sun protection and minimizing UV radiation exposure for people with fair skin who are between the ages of 6 months to 24 years, in order to reduce skin cancer risk. The task force also recommends selectively offering counseling to adults older than age 24 years with fair skin, although existing evidence suggests there is only a small net benefit from counseling these patients.
Question 4
Answer
D.Skin self-examination counseling among adults.
According to the USPSTF 2018 updated recommendations for preventing skin cancer, there is insufficient evidence to determine if counseling adults on skin self-examination practices changes their behavior or affects skin cancer risk. However, the Task Force found evidence to support recommendations for counseling on sun-protection behaviors for children, adolescents, young adults, and adults older than age 24 years who have fair skin types.
Question 5
Answer
A.Airline flight attendants
The study, published in Environmental Health, bolstered previous findings about elevated cancer risks among flight crews. The study authors noted that skin cancer prevalence was higher among male flight attendants who had been exposed to high levels of secondhand smoke before the 1998 airline smoking ban.
“We want to make sure we are not producing a financial burden for patients in exchange for that convenience [with subcutaneous therapies],” said Thaddeus Beck, MD, FACP.
Marcio A. Fagundes, MD, explained how proton therapy and rectal spacers can reduce radiation exposure to the rectum, bowel, and bladder in prostate cancer.
Bruce Haffty, MD, and Mutlay Sayan, MD, on building radiation oncology at Rutgers, the future of the field, and a remarkable journey from eastern Turkey to Harvard faculty.
Marcio A. Fagundes, MD, discussed disease control by risk group among 404 patients with prostate cancer treated with intensity-modulated proton therapy.
The approval expands the indication of pirtobrutinib to patients with previously untreated chronic lymphocytic leukemia/small lymphocytic lymphoma with no known 17p deletion.